EWA
AUTL

EverSource Wealth Advisors’s Autolus Therapeutics AUTL Stock Holding History

EverSource Wealth Advisors’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-163
Closed -$324 – 4394
2025
Q4 		$324 Sell
163
-1,502
-90% -$2.31K ﹤0.01% 3953
2025
Q3 		$2.71K Buy
1,665
+101
+6% +$197 ﹤0.01% 3410
2025
Q2 		$3.57K Sell
1,564
-4,548
-74% -$7.52K ﹤0.01% 3295
2025
Q1 		$9.47K Buy
+6,112
New +$12.4K ﹤0.01% 2139

Other funds holding AUTL

MCO
MAK Capital One New York $604M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $509M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return